SHIV SAGIV sold (to issuer) 50,000 shares of MRAI
SHIV SAGIV sold (to issuer) 50,000 shares of Marpai, Inc. (MRAI) on 2025-12-08 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Insider sales can influence sentiment, but 10b5-1 pre-arranged activity and lack of disclosed price/value generally make the trading signal weak.
Market read
A single insider sale disclosure with limited new fundamental information; any market impact is likely small.
What to watch
The filing does not disclose sale price or total value, limiting inference; also, “sale to issuer” can be tied to structured buyback mechanics rather than open-market selling.
Background
The filing is an SEC Form 4 insider transaction for Marpai, Inc., showing a director’s sale of 50,000 shares under a pre-arranged 10b5-1 plan.
Ticker impact
Director SHIV SAGIV sold 50,000 shares of Marpai, Inc. under a pre-arranged Rule 10b5-1 plan, disclosed via SEC Form 4.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
Form 4 reports a sale to the issuer (buyback participation) and notes a pre-arranged 10b5-1 plan, which typically reduces signal strength versus discretionary selling.
Market effects
Minimal; this is company-specific insider transaction disclosure with no sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
Because it’s a 10b5-1 plan and sale is to the issuer, the transaction may reflect liquidity/plan mechanics rather than bearish expectations.
Key entities
- issuerMarpai, Inc.
Subject of the SEC Form 4 insider transaction; director SHIV SAGIV sold 50,000 shares.
- directorSHIV SAGIV
Director who executed the reported sale under a Rule 10b5-1 plan.
